vs
DHT Holdings, Inc.（DHT）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
IONIS PHARMACEUTICALS INC的季度营收约是DHT Holdings, Inc.的1.9倍（$203.3M vs $107.3M），DHT Holdings, Inc.净利率更高（41.7% vs -112.8%，领先154.6%），IONIS PHARMACEUTICALS INC同比增速更快（-10.3% vs -24.5%）
DHT控股是一家独立的国际原油运输企业，持有并运营大型原油运输船队，主要服务全球油气行业，为头部石油生产商、炼油厂和大宗商品贸易商提供跨国际核心贸易航线的原油海运服务。
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
DHT vs IONS — 直观对比
营收规模更大
IONS
是对方的1.9倍
$107.3M
营收增速更快
IONS
高出14.2%
-24.5%
净利率更高
DHT
高出154.6%
-112.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.3M | $203.3M |
| 净利润 | $44.8M | $-229.4M |
| 毛利率 | — | 96.1% |
| 营业利润率 | 44.2% | -105.5% |
| 净利率 | 41.7% | -112.8% |
| 营收同比 | -24.5% | -10.3% |
| 净利润同比 | 27.3% | -119.8% |
| 每股收益（稀释后） | $0.28 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHTIONS
| Q4 25 | — | $203.3M | ||
| Q3 25 | $107.3M | $156.7M | ||
| Q2 25 | — | $452.0M | ||
| Q1 25 | — | $131.6M | ||
| Q4 24 | — | $226.6M | ||
| Q3 24 | $142.1M | $133.8M | ||
| Q2 24 | — | $225.3M | ||
| Q1 24 | — | $119.5M |
净利润DHTIONS
| Q4 25 | — | $-229.4M | ||
| Q3 25 | $44.8M | $-128.6M | ||
| Q2 25 | — | $123.6M | ||
| Q1 25 | — | $-146.9M | ||
| Q4 24 | — | $-104.3M | ||
| Q3 24 | $35.2M | $-140.5M | ||
| Q2 24 | — | $-66.3M | ||
| Q1 24 | — | $-142.8M |
毛利率DHTIONS
| Q4 25 | — | 96.1% | ||
| Q3 25 | — | 98.5% | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | — | 98.9% | ||
| Q4 24 | — | 98.3% | ||
| Q3 24 | — | 99.2% | ||
| Q2 24 | — | 98.2% | ||
| Q1 24 | — | 98.2% |
营业利润率DHTIONS
| Q4 25 | — | -105.5% | ||
| Q3 25 | 44.2% | -102.2% | ||
| Q2 25 | — | 30.9% | ||
| Q1 25 | — | -111.6% | ||
| Q4 24 | — | -48.9% | ||
| Q3 24 | 29.7% | -111.1% | ||
| Q2 24 | — | -29.3% | ||
| Q1 24 | — | -125.1% |
净利率DHTIONS
| Q4 25 | — | -112.8% | ||
| Q3 25 | 41.7% | -82.1% | ||
| Q2 25 | — | 27.3% | ||
| Q1 25 | — | -111.6% | ||
| Q4 24 | — | -46.1% | ||
| Q3 24 | 24.8% | -105.0% | ||
| Q2 24 | — | -29.4% | ||
| Q1 24 | — | -119.5% |
每股收益（稀释后）DHTIONS
| Q4 25 | — | $-1.35 | ||
| Q3 25 | $0.28 | $-0.80 | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $-0.93 | ||
| Q4 24 | — | $-0.66 | ||
| Q3 24 | $0.22 | $-0.95 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.3M | $2.7B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $1.1B | $489.1M |
| 总资产 | $1.4B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资DHTIONS
| Q4 25 | — | $2.7B | ||
| Q3 25 | $81.3M | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $73.8M | $2.5B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.2B |
总债务DHTIONS
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DHTIONS
| Q4 25 | — | $489.1M | ||
| Q3 25 | $1.1B | $618.0M | ||
| Q2 25 | — | $631.7M | ||
| Q1 25 | — | $475.7M | ||
| Q4 24 | — | $588.4M | ||
| Q3 24 | $1.0B | $662.5M | ||
| Q2 24 | — | $263.7M | ||
| Q1 24 | — | $296.5M |
总资产DHTIONS
| Q4 25 | — | $3.5B | ||
| Q3 25 | $1.4B | $3.0B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $1.5B | $3.1B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.8B |
负债/权益比DHTIONS
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-159.0M |
| 自由现金流率自由现金流/营收 | — | -78.2% |
| 资本支出强度资本支出/营收 | — | 10.5% |
| 现金转化率经营现金流/净利润 | 1.36× | — |
| 过去12个月自由现金流最近4个季度 | — | $-320.0M |
8季度趋势，按日历期对齐
经营现金流DHTIONS
| Q4 25 | — | $-137.7M | ||
| Q3 25 | $60.9M | $-131.4M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $-150.8M | ||
| Q4 24 | — | $-116.1M | ||
| Q3 24 | $80.1M | $-115.0M | ||
| Q2 24 | — | $-119.9M | ||
| Q1 24 | — | $-149.9M |
自由现金流DHTIONS
| Q4 25 | — | $-159.0M | ||
| Q3 25 | — | $-136.7M | ||
| Q2 25 | — | $139.0M | ||
| Q1 25 | — | $-163.4M | ||
| Q4 24 | — | $-141.6M | ||
| Q3 24 | — | $-124.0M | ||
| Q2 24 | — | $-126.1M | ||
| Q1 24 | — | $-154.4M |
自由现金流率DHTIONS
| Q4 25 | — | -78.2% | ||
| Q3 25 | — | -87.2% | ||
| Q2 25 | — | 30.8% | ||
| Q1 25 | — | -124.1% | ||
| Q4 24 | — | -62.5% | ||
| Q3 24 | — | -92.7% | ||
| Q2 24 | — | -56.0% | ||
| Q1 24 | — | -129.2% |
资本支出强度DHTIONS
| Q4 25 | — | 10.5% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 3.8% |
现金转化率DHTIONS
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | — | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHT
暂无分部数据
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
